THARROS is a phase III study of inhaled combinations of molecules aimed at controlling the cardiopulmonary effects associated with chronic obstructive pulmonary disease.
You may receive one of the two combinations of medications. The treatment is administered by inhalation.
To participate, you must have received a diagnosis of COPD.
Clic here to access the official record from the National Library of Medicine for this study